1 Sautès-Fridman C, Lawand M, Giraldo NA, Kaplon H, Germain C, Fridman WH, Dieu-Nosjean MC. 2016. Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention. Front. Immunol. 7, 407.

2 Slaney CY, Kershaw MH, Darcy PK. 2014. Trafficking of T Cells into Tumors. Cancer Res. 74(24). 7168-7174.

3 Marelli-Berg FM, Clement M, Mauro C, Caligiuri G. 2013. An immunologist’s guide to CD31 function in T-cells. J Cell Sci 126, 2343-2352.

4 Mody PD, Cannon JL, Bandukwala HS, Blaine KM, Schilling AB, Swier K, Sperling AI. 2007. Signaling through CD43 regulates CD4 T-cell trafficking. Blood. 110(8), 2974-2982.

5 Baaten BJ, Li CR, Bradley LM. 2010. Multifaceted regulation of T cells by CD44. Commun Integr Biol. 3(6), 508-512.

6 Fridman WH, Pagès F, Sautès-Fridman C, Galon J. 2012. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12, 298-306.

7 Wherry EJ, Kurachi M. 2015. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15, 485-499.

8 Kim HJ, Cantor H. 2014. CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful. Cancer Immunol Res. Feb;2(2):91-8.

9 Tabbekh M, Mokrani-Hammani M, Bismuth G, Mami-Chouaib F. 2013. T-cell modulatory properties of CD5 and its role in antitumor immune responses. Oncoimmunology 2(1), e22841.

이 외에 다른 문의 사항이 있으시면 1:1문의(click!)를 통해 상담 가능합니다.